Study of regeneration treatment with cobalt chloride-induced retinal degeneration model
Project/Area Number |
22590239
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Gifu University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
HARA Akira 岐阜大学, 大学院・医学系研究科, 教授 (10242728)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 再生医学 / 中枢神経 / 網膜 / 神経障害 / ES細胞 / コバルトクロライド / NMDA / 奇形種発現 / ES細胞 / 再生 / 奇形種 / 網膜障害 / 再生治療 |
Research Abstract |
The ultimate goal of this study is treatment of retinal degeneration by regeneration. As a pre-stage, we constructed suitable regeneration condition using retinal degeneration model treating with CoCl2or NMDA. The results indicate hypoxia condition might be good for neuronal differentiation, and herpes simplex virus-thymidine kinase transgene transfected ES cells is good for prevention of expression of teratoma.
|
Report
(4 results)
Research Products
(24 results)